One of Northern Ireland’s biggest pharma firms has suffered a big profits slump in a year which saw 140 staff being made redundant amid rising costs.
The Newry veterinary pharmaceuticals group Norbrook saw it profits squeezed to the lowest level in more than a decade during 2023, as the company faced increased competition from India and China.
LIAM Nagle will stand down from his role as chief executive of Newry-based veterinary pharma firm Norbrook Laboratories at the end of this year, but will stay on as chairman.